Guidance
The National Institute for Health and Clinical Excellence (NICE) has issued full guidance to the NHS in England, Wales, Scotland and Northern Ireland on Percutaneous radiofrequency ablation for primary or secondary lung cancers.
It replaces the previous guidance on Percutaneous radiofrequency ablation for primary or secondary lung cancers (NICE interventional procedures guidance 185, July 2006).
Description
Percutaneous radiofrequency ablation of cancer in the lung involves inserting one or more electrodes (needle-like probes) through the chest into the lung. The electrodes are placed within the tumour and connected to a source of electrical current, producing heat with the aim of destroying (‘ablating’) the cancer cells.
Coding and clinical classification codes for this guidance